• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

    5.817 +0.967 (+19.94%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Jul 31, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CNS Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2
    ...
    17 18 19 20 21 22 23 24 Next >
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2022 Financial Results, Corporate Update
    Via Investor Brand Network
    Researchers Want to Manage Cancer By Keeping Malignant Cells Restricted in Place
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Positioning Berubicin Clinical Development Program for Success
    Via Investor Brand Network
    Study Suggests That Test of Memory May Signal Brain Tumor Presence
    Via Investor Brand Network
    Symptoms of Brain Tumors To Watch For
    Via Investor Brand Network
    News headline image
    CNS Pharmaceuticals: Q1 Earnings Insights ↗
    CNS Pharmaceuticals (NASDAQ:CNSP) reported its Q1 earnings results on Monday, May 16, 2022 at 08:35 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Study Finds That Ketogenic Diet May Help Patients with Brain Cancer
    Via Investor Brand Network
    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Advances Drug Candidate to Fight Aggressive Brain Cancer Amid Difficult Era for Market
    Via Investor Brand Network
    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expanding Scope of Potentially Pivotal Study as Part of Clinical Program to Develop GBM Treatment
    Via Investor Brand Network
    Researchers Develop Blood Test to Improve Tumor Diagnosis, Monitoring
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Urges Shareholders to Vote in Favor of Proxy Proposals for Upcoming Annual Meeting
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Expanding Patient Eligibility in Potentially Pivotal Berubicin Trial
    Via Investor Brand Network
    Preclinical Study Uncovers Potential Key to Treating Deadly Brain Tumors
    Via Investor Brand Network
    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expands Patient Eligibility for Brain Cancer Drug Trial, Receives Approval from U.S. FDA for Protocol Amendment
    Via Investor Brand Network
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    AI May Help Improve Brain Cancer Diagnosis
    Via Investor Brand Network
    Topics Artificial Intelligence
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures FDA Approval for Protocol Amendment to Ongoing Potentially Pivotal Berubicin Trial
    Via Investor Brand Network
    News headline image
    44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More ↗
    Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering. 
    Via Benzinga
    Study Suggests Healthcare Workers Don’t Know Enough About Childhood Brain Tumors
    Via Investor Brand Network
    Study Finds That Brain Tumors May Originate from Different Site
    Via Investor Brand Network
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    Exposure to Wildfires Amplifies Cancer Risk, New Study Finds
    Via Investor Brand Network
    Genomic Sequencing Offers Hope in Diagnosis, Treatment of Brain Tumors
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at H.C. Wainwright Global Investment Conference
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Among Most Powerful of Chemotherapy Drugs
    Via Investor Brand Network
    Lantern Pharma to Host Glioblastoma Multiforme Webinar to Mark Brain Tumor Awareness Month
    Via Investor Brand Network
    Topics Artificial Intelligence
    BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Abstract to be Presented at American Society of Clinical Oncology 2022 Annual Meeting
    Via Investor Brand Network
    Updated Guidelines Shed Light on Using Radiation Against Brain Metastases
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2022 Financial, Corporate Update
    Via Investor Brand Network
    Researchers Develop Models to Better Understand Brain Cancer Metastasis
    Via Investor Brand Network
    < Previous 1 2
    ...
    17 18 19 20 21 22 23 24 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.